AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimnac MP 2mg/500mg/15mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Spencure Biotech Pvt. Ltd.

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (15mg)

Overview Glimnac MP 2mg/500mg/15mg Tablet SR

Diabetic patients using Glimnac MP 2mg/500mg/15mg SR tablets, an anti-diabetic combination medication, should adhere to prescribed dosages. This medication manages type 2 diabetes in adults by regulating blood glucose. Administer this extended-release tablet with food, consistently at the same time daily for optimal efficacy. Dosage adjustments are determined by your physician based on blood sugar monitoring. Continuous use is vital; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. A comprehensive diabetes management plan, encompassing diet, exercise, and weight control as directed by your doctor, is crucial. Hypoglycemia (low blood sugar) is a common side effect; learn to identify symptoms (sweating, dizziness, headache, tremors) and manage them promptly with fast-acting glucose (e.g., sugary foods or juice). Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, swelling, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, or severe liver/kidney disease. Inform your physician of any heart condition history before initiating treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood sugar checks and potential blood tests (blood cell counts, liver function) are necessary for ongoing monitoring.

Uses of Glimnac MP 2mg/500mg/15mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimnac MP 2mg/500mg/15mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Glimnac MP 2mg/500mg/15mg Sustained-Release tablet should be administered on an empty stomach.

Common Side effects of Glimnac MP 2mg/500mg/15mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimnac MP 2mg/500mg/15mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimnac MP 2mg/500mg/15mg Tablet SR whole; do not chew, crush, or divide it. Administer on an empty stomach.

How Glimnac MP 2mg/500mg/15mg Tablet SR works:

Extended-release Glimnac MP tablets (2mg/500mg/15mg) contain a triple combination of antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimnac MP 2mg/500mg/15mg SR tablets with alcohol is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimnac MP 2mg/500mg/15mg tablet might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Glimnac MP 2mg/500mg/15mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

The use of Glimnac MP 2mg/500mg/15mg SR tablets is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, this medication is contraindicated in patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Exercise caution when administering Glimnac MP 2mg/500mg/15mg SR tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, initiate Glimnac MP 2mg/500mg/15mg SR tablets at a reduced dosage; its use is contraindicated in cases of severe liver disease.

What if you forget to take Glimnac MP 2mg/500mg/15mg Tablet SR :

Should you forget to take your Glimnac MP 2mg/500mg/15mg Tablet SR, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.

Facts to Know About Glimnac MP 2mg/500mg/15mg Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glimnac MP 2mg/500mg/15mg Tablet SR

Glimnac MP SR tablets (2mg/500mg/15mg) combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 diabetes.
Glimnac MP 2mg/500mg/15mg SR tablets may cause common side effects including hypoglycemia, nausea, diarrhea, taste changes, gas, stomach pain, headache, rash, and respiratory infections.
Glimnac MP 2mg/500mg/15mg Tablet SR is contraindicated in patients allergic to its components or excipients, those with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis (including diabetic ketoacidosis).
Combining Glimnac MP 2mg/500mg/15mg SR tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimnac MP 2mg/500mg/15mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimnac MP 2mg/500mg/15mg...
75
MRP 91
17% off